BIIB
31
-7
EL
45
5
DOW
42
3
UNP
48
2
JWN
55
5
TDC
65
-2
HIG
59
3
BBY
38
-4
EXC
47
2
ACN
54
-5
CAG
34
3
PVH
53
4
AMP
69
2
T
42
4
CF
36
-5
GS
65
5
SYK
40
3
IR
58
3
WBA
51
6
EIX
61
2
BIIB
31
-7
EL
45
5
DOW
42
3
UNP
48
2
JWN
55
5
TDC
65
-2
HIG
59
3
BBY
38
-4
EXC
47
2
ACN
54
-5
CAG
34
3
PVH
53
4
AMP
69
2
T
42
4
CF
36
-5
GS
65
5
SYK
40
3
IR
58
3
WBA
51
6
EIX
61
2
Financhill
Back

Cue Biopharma Vs. GlycoMimetics Industry Stock Comparison

Buy
75

CUE
Cue Biopharma

Last Price:
1.68
Seasonality Move:
27.28%
Buy
54

GLYC
GlycoMimetics

Last Price:
0.49
Seasonality Move:
50.06%
Buy
75
Cue Biopharma (CUE) is a Buy

Is Cue Biopharma a Buy, Sell or Hold?

  • The current Cue Biopharma [CUE] share price is $1.78. The Score for CUE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • CUE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
GlycoMimetics (GLYC) is a Buy

Is GlycoMimetics a Buy, Sell or Hold?

  • The current GlycoMimetics [GLYC] share price is $0.17. The Score for GLYC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • GLYC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CUE Stock Price Chart

What is Cue Biopharma's stock price today?

  • The Cue Biopharma share price today is $1.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CUE is experiencing buying pressure, which is a positive indicator for future bullish movement.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

  • The GlycoMimetics share price today is $0.17
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLYC is experiencing selling pressure, which indicates risk of future bearish movement.

CUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.23 Buy
Relative Strength Index (14 RSI): 71.61 Buy
Chaikin Money Flow: 514836 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.7 - 1.5) Buy
Bollinger Bands (100): (0.6 - 1.3) Buy

GLYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 53.49 Buy
Chaikin Money Flow: -967323 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.15 - 0.17) Buy
Bollinger Bands (100): (0.15 - 0.27) Sell

CUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.49 Buy
20-day SMA: 1.24 Buy
50-day SMA: 0.88 Buy
200-day SMA: 1.49 Buy
8-day EMA: 1.52 Buy
20-day EMA: 1.28 Buy
50-day EMA: 1.04 Buy
200-day EMA: 1.45 Buy

GLYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.17 Buy
20-day SMA: 0.16 Buy
50-day SMA: 0.17 Buy
200-day SMA: 1.22 Sell
8-day EMA: 0.17 Buy
20-day EMA: 0.16 Buy
50-day EMA: 0.19 Sell
200-day EMA: 0.81 Sell

Cue Biopharma Earnings Growth & CUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.07 per share.

GlycoMimetics Earnings Growth & GLYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.12 per share.

Cue Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

GlycoMimetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):